AI assistant
Sending…
HARTE HANKS INC — Director's Dealing 2003
Feb 14, 2003
34832_dirs_2003-02-14_893198f4-1486-4d21-816b-bd43ce9ec5af.zip
Director's Dealing
Open in viewerOpens in your device viewer
4 1 rrd5110.htm FORM 4 SEC Form 4
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response. . . . . 0.5
- Name and Address of Reporting Person * Hochhauser, Richard M. (Last) (First) (Middle) 55 Fifth Avenue, 14th Floor (Street) New York , NY 10003 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Harte-Hanks, Inc. HHS 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) 4. Statement for (Month/Day/Year 02/14/2003 5. If Amendment, Date of Original (Month/Day/Year) 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Description President and Chief Operating Officer 7. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned — 1. Title of Security (Instr. 3) | 2.Transaction Date (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4, and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Owner- ship Form: Direct (D) or Indirect (I) (Instr. 4) | |||
|---|---|---|---|---|---|---|---|---|
| Code | V | Amount | A/D | Price | ||||
| Common Stock | 02/14/2003 | S | 20,000 | D | $18.00 | 321,012 | D |
| 4. Transaction Code (Instr.8) | 5. Number of Derivative Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable(DE) and Expiration Date(ED) (Month/Day/Year) | 7. Title and Amount of Underlying Securities (Instr. 3 and 4) | 8. Price of Derivative Security (Instr.5) | |||
|---|---|---|---|---|---|---|---|
| Code | V | A | D DE ED Title Amount or Number of Shares | DE | ED | Title | Amount or Number of Shares |
Explanation of Responses:
| By: | Date: |
|---|---|
| /s/ Dean H. Blythe | 02/14/2003 |
| Power of Attorney | |
| ** Signature of Reporting Person | SEC 1474 (9-02) |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations | |
| See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
More from HARTE HANKS INC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Mar 17
Annual Report
2026
Mar 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2025
Dec 15
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Dec 10